Advertisement Millipore opens expanded facility in St Charles, Missouri - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Millipore opens expanded facility in St Charles, Missouri

Millipore has unveiled a major expansion of its St Charles, Missouri facility –headquarters for its drug discovery business unit.

Millipore is seeking LEED certification of the expanded and renovated 17,000-square-foot space, which is just one of Millipore’s three buildings on the 43-acre Missouri Research Park campus.

The newly expanded and renovated space houses laboratories, administrative offices and an enlarged break area. Millipore plans to hire an additional 60 employees at the St Charles site, which currently employs 187 people.

The $3.4 million expansion is expected to enable Millipore to keep pace with the growth of its worldwide drug discovery and development business, which provides products and services that help pharmaceutical and biotechnology companies discover, evaluate and develop drug candidates.

Rick Ryan, vice president of Millipore’s drug discovery business unit, said: “Our expanded St Charles facility will help us meet the needs of customers at every stage of the drug discovery and development pipeline – from target identification through clinical studies. It will also enable us to continue to expand our workforce in the greater St Louis region.”